What is CRISPR Therapeutics's investment proceeds?

CRISPR Therapeutics (CRSP) reported investment proceeds of $175.5K in Q4 2025.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

CRISPR Therapeutics CRSP Investment Proceeds

Investment Proceeds at other companies

CG OncologyCGON

$252.85M+26.3%

Arrowhead ResearchARWR

$115.34M-2.4%

BridgeBio PharmaBBIO

$10M—

Krystal Biotech, Inc.KRYS

$103.6M+16.7%

Spyre Therapeutics, Inc.SYRE

$107.75M+50.9%

IncyteINCY

$0-100%

Other financials

Income statement

See full

Revenue$1.5M+68.6%

Operating income-$130.2M+12.2%

Net income-$122.9M+9.6%

EPS (diluted)-$1.28+19.0%

Balance sheet

See full

Cash & equivalents$423.3M+80.0%

Total debt$787.6M+259%

Total equity$1.8B-0.8%

Total assets$2.7B+25.8%

Cash flow

See full

Operating cash flow-$108.9M-102%

CapEx$504.0K+145%

Free cash flow-$109.4M-102%

Valuation

See full

Market cap$5.33B+56.4%

Enterprise value$5.69B+69.8%

P/S1,298.3×+1,208×

Profitability

See full

Operating margin-15,754.2%-17,253pp

Net margin-13,856.5%-15,058pp

FCF margin-9,777.6%-10,759pp

Returns & leverage

See full

Return on equity-31.2%+43.7pp

Debt / equity0.4×+0.3×

Current ratio18×+2.3×

Where this comes from

Reported directly by CRISPR Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi.

The official record: CRISPR Therapeutics’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CRISPR Therapeutics's investment proceeds?: CRISPR Therapeutics (CRSP) reported investment proceeds of $175.5K in Q4 2025.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.